Intermediate cancer biomarkers and their use in beta-carotene studies in humans

International Journal for Vitamin and Nutrition Research

Volumn 66, Issue 1, 1996, Pages 2-18

  Gerster, Helga ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Adenomas; Beta carotene; Connexin43; Dysplasias; Intermediate cancer markers; Leukoplakias; Lipid peroxidation products; Micronuclei; mRNA; Mutated p53; Ornithine decarboxylase activity

Indexed keywords

BETA CAROTENE; CAROTENOID; TUMOR MARKER;

CHEMOPROPHYLAXIS; CLINICAL TRIAL; FEMALE; HUMAN; MALE; NEOPLASM; REVIEW;

BETA CAROTENE; CAROTENOIDS; CHEMOPREVENTION; CLINICAL TRIALS; FEMALE; HUMANS; MALE; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030044926     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (83)

1. Van Poppel, G. (1993) Carotenoids and cancer: an update with emphasis on human intervention studies. Eur. J. Cancer 29, 1335-1344.
2. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers N. Engl. J. Med. 330, 1029-1035.
3. Pryor, W.A. (1994) Betacarotene, vitamin E, and lung cancer (Letter). N. Engl. J. Med. 331, 612.
4. Jacob, R.A. (1994) The case for vitamin supplementation. J. Am. Coll. Nutr. 13, 111-112.
5. Greenberg, E.R. (1993) Retinoids or carotenoids: is there another choice? Prev. Med. 22, 723-727.
6. Krinsky, N.J. (1993) Micronutrients and their influence on mutagenicity and malignant transformation. Ann, NY Acad. Sci. 686, 229-242.
7. Gerster, H. (1995) β-Carotene, vitamin E and vitamin C in different stages of experimental carcinogenesis. Eur, J. Clin. Nutr. 49, 155-168.
8. Rousseau, E.J., Davison, A.J. and Dunn, B. (1992) Protection by β-carotene and related compounds against oxygen-mediated cytotoxicity and genotoxicity: implications for carcinogenesis and amicarcinogenesis. Free Rad. Biol. Med. 13, 407-433.
9. Krinsky, N.J. (1993) Actions of carotenoids in biological systems. Annu. Rev. Nutr. 13, 561-587.
10. Gerster, H. (1993) Anticarcinogenic effect of common carotenoids. Int. J. Vit. Nutr. Res. 63, 93-121.
11. Ames, B.N. and Gold, L.S. (1990) Too many rodent carcinogens: Mitogenesis increases mutagenesis. Science 249, 970-971.
12. Cerutti, P.A. (1994) Oxy-radicals and cancer. Lancet 344, 862-863.
13. Kehrer, J.P. and Smith C.V. (1994) Free radicals in biology: sources, reactivities, and roles in the etiology of human diseases. In: B. Frei (ed.). Natural Antioxidants in Human Health and Disease. Academic Press, San Diego, pp. 25-62.
14. Grinberg-Funes, R.A., Singh V.N., Perera, F.P., Bell, D.A., Young, T.L., Dickey, C., Wang, S.W. and Santella, R.M. (1994) Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and the glutathione-S-transferase MI genotype. Carcinogenesis 15, 2449-2454.
15. Loft, S., Vistisen, K., Ewertz, M., Tjonneland, Overvad, K. and Poulsen, H.E. (1992) Oxidative damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 13, 2241-2247.
16. Frenkel, K. (1992) Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmacol. Ther. 53, 127-166.
17. Ames, B.N. and Shigenaga, M.K. (1993) Oxidants are a major contributor to cancer and aging. In: B. Halliwell and O.I. Aruoma (eds.). DNA and Free Radicals. Ellis Horwood Ltd, London, pp. 1-15.
18. Hartwell, L.H. and Kastan, M.B. (1994) Cell cycle control and cancer. Science 266, 1821-1828.
19. Boutwell, R.K. (1983) Biology and biochemistry of the two-step model of carcinogenesis. In: F. Meyskens and K. Prasad (eds.). Modulation and Mediation of Cancer by Vitamins. Karger, Basel, pp. 2-9.
20. Cerutti, P.A. (1985) Prooxidant states and tumor promotion. Science 227, 375-381.
21. Clemens, M.R. (1991) Free radicals and chemical carcinogenesis. Klin. Wochenschrift 69, 1123-1134.
22. Marsh, J.P., Janssen, Y.M.W. and Mossman, B.T. (1993) Ornithine decarboxylase and tumor promotion: a role for oxidants. In: B. Halliwell and O.I. Aruoma (eds.). DNA and Free Radicals. Ellis Horwood Ltd, London, pp. 229-240.
23. Love, R.R., Surawicz, T.S., Morrissey, J.F. and Verma, A.K. (1992) Levels of colorectal ornithine decarboxylase activity in patients with colon cancer, a family history of nonpolyposis hereditary colorectal cancer, and adenomas. Cancer Epidemiol. Biomark. Prev. 1, 195-198.
24. Sandier, R.S., Ulshen, M.H., Lyles, C.M., McAuliffe, C.A. and Fuller C.R. (1992) Rectal mucosal ornithine decarboxylase activity is not a useful marker of risk for colorectal neoplasia. Dig. Dis. Sci. 37, 1718-1724.
25. Garewal, H.S., Gerner, E.W., Sampliner R.E. and Roe, D. (1988) Ornithine decarboxylase and polyamine levels in columnar upper gastrointestinal mucosae in patients with Barrett's esophagus. Cancer Res. 48, 3288-3291.
26. Bertram, J.S. (1991) Cancer prevention by retinoids and carotenoids: proposed role of gap junctional communication. In: M.M. Jacobs (ed.). Vitamins and Minerals in the Prevention and Treatment of Cancer. CRC Press, Boca Raton, pp. 31-50.
27. Zhang, L.X., Cooney R.V. and Bertram, J.S. (1991) Carotenoids enhance gap junction communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis 12, 2109-2114.
28. Springfield, J.R. and Levitt, M.D. (1994) Pitfalls in the use of breath pentane measurements to assess lipid peroxidation. J. Lipid Res. 35, 1497-1504.
29. Kneepkens, C.M.F., Lepage, G. and Roy, C.C. (1994) The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Rad. Biol. Med. 17, 127-160.
30. Stich H.F. and Rosin, M.P. (1984) Micronuclei in exfoliated human cells as a tool for studies in cancer risk and cancer intervention. Cancer Lett. 22, 241-253.
31. Moore, L.E., Titenko-Holland, N., Quintana, P.J.E. and Smith, M.T. (1993) Novel biomarkers of genetic damage in humans: use of fluorescence in situ hybridization to detect aneuploidy and micronuclei in exfoliated cells. J. Toxicol. Environm. Health 40, 349-357.
32. Boone, C.W. and Kelloff, G.J. (1993) Intraepithelial neoplasia, surrogate endpoint biomarkers, and cancer chemoprevention. J. Cell. Biochem. 17F, 37S-48S.
33. Wright, J.M. (1994) Oral precancerous lesions and conditions. Semin. Dermatol. 13, 125-131.
34. Fearon, E.R. and Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell. 61, 759-767.
35. Kelloff, G.J., Boone, C.W., Steele, V.E., Crowell, J.A., Lubet, R. and Sigman, C.C. (1994) Progress in cancer chemoprevention: Perspectives on agent selection and short-term clinical intervention trials. Cancer Res. 54, 2015S-2024S.
36. Neugut, A.I., Jacobson, J.S. and De Vivo, I. (1993) Epidemiology of colorectal adenomatous polyps. Cancer Epidemiol. Biomarkers Prev. 2, 159-176.
37. Allard, J.P., Royall, D., Kurian, R., Muggli, R. and Jeejeebhoy, K.N. (1994) Effects of beta-carotene supplementation on lipid peroxidation in humans. Am. J. Clin. Nutr. 59, 884-890.
38. Gottlieb, K., Zarling, E.J., Mobarhan, S., Bowen, P. and Sugerman, S. β-Carotene decreases markers of lipid peroxidation in healthy volunteers. Nutr. Cancer 19, 207-212.
39. Dixon, Z.R., Burri, B.J., Clifford, A., Frankel, E.N., Schneeman, B.O., Parks, E., Keim, N.L., Barbieri, T., Wu M.-M., Fong, A.K.H., Kretsch, M.J., Sowell A.L. and Erdman, J.W. (1994) Effects of a carotene-deficient diet on measures of oxidative susceptibility and superoxide dismutase activity in adult women. Free Rad. Biol. Med. 17, 537-544.
40. Franke, A.A., Harwood, P.J., Shimamoto, T., Lumeng, S., Zhang, L.-X., Bertram, J.S., Wilkens, L.R., Marchand, L.L. and Cooney, R.V. (1994) Effects of micronutrients and antioxidants on lipid peroxidation in human plasma and in cell cultures. Cancer Lett. 79, 17-26.
41. Stich, H.F., Rosin, M.P. and Vallejera, M.O. (1984) Reduction with vitamin A beta-carotene administration of proportion of micronucleated buccal mucosal cells in Asian betel nut and tobacco chewers. Lancet 1, 1204-1206.
42. Van Poppel, G., Poulsen, H., Loft, S. and Verhagen, H. (1995) No influence of beta carotene on oxidative DNA damage in male smokers. J. Natl. Cancer Inst. 87, 310-311.
43. Van Poppel, G., Kok, F.J., Duijzings, P. and de Vogel, N. (1992) No influence of beta-carotene on smoking induced DNA damage as reflected by sister chromatid exchanges. Int. J. Cancer 57, 355-358.
44. Benner, S.E., Lippman, S.M and Hong, W.K. (1994) Chemoprevention of second primary tumours: A model for intervention trials. Eur. J. Cancer 30, 727-729.
45. Lippman, S.M., Spitz, M., Trizna, Z., Benner, S.E. and Hong, W.K. (1994) Epidemiology, biology and chemoprevention of aerodigestive cancer. Cancer 74, 19-25.
46. Stich, H.F., Tsang, S.S., Palcic, B., Mathew, B., Sankaranarayanan, R. and Nair, M.K. (1990) The usefulness of in vitro assays and animal experiments in the design of chemopreventive protocols with beta-carotene and vitamin A on tobacco chewers. In: K.N. Prasad and F.L. Meyskens (eds.). Nutrients and Cancer Prevention. The Humana Press, pp. 119-134.
47. Benner, S.E., Lippman, S.M., Wargovich, M.J., Lee, J.J., Velasco, M. and Martin, J.W. (1994) Micronuclei, a biomarker for chemoprevention trials: results of a randomized study in oral pre-malignancy. Int. J. Cancer 59, 457-459.
48. Stich, H.F., Mathew, B., Sankaranarayanan, R. and Nair, M.K. (1991) Remission of precancerous lesions in the oral cavity of tobacco chewers and maintenance of the protective effect of β-carotene or vitamin A. Am. J. Clin. Nutr. 53, 298S-304S.
49. Stich, H.F., Rosin, M.P., Hornby, A.P., Mathew, B., Sankaranarayanan, R. and Nair, M.K. (1988) Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-carotene and with beta-carotene plus vitamin A. Int. J. Cancer 42, 195-199.
50. Stich, H.F., Brunnemann, K.D., Mathew, B., Sankaranarayanan, R. and Nair, M.K. (1989) Chemopreventive trials with vitamin A and β-carotene: some unresolved issues. Prev. Med. 18, 732-739.
51. Lippman, S.M., Batsakis, J.G., Toth, B.B., Weber, R.S., Lee, J.J., Martin, J.W., Hays, G.L., Goepfert, H. and Hong, W.K. (1993) Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N. Engl. J. Med. 328, 15-20.
52. Malaker, K., Anderson, B.J., Beecroft, W.A. and Hodson, D.I. (1991) Management of oral mucosal dysplasia with β-carotene retinoic acid: A pilot cross-over study. Cancer Detect Prev. 15, 335-340.
53. Toma, S., Benso, S., Albanese, E., Palumbo, R., Cantoni, E., Nicolo, G. and Mangiante, P. (1992) Treatment of oral leukoplakia with beta-carotene. Oncology 49, 77-81.
54. Toma, S., Bonelli, G., Cortesina, G., Gandolfo, G., Mira, E., Sartoris, A., Radaelli De Zinis, L., Vincenti, M. and Palumbo, R. (1995) Beta-carotene in head and neck tumors chemoprevention. Am. J. Clin. Nutr. Suppl., in press.
55. Garewal, H.S., Meyskens, F.L. and Killen, D. (1990) Response of oral leukoplakia to beta-carotene. J. Clin. Oncol. 8, 1715-1720.
56. Garewal, H.S. (1993) Beta-carotene and vitamin E in oral cancer prevention. J. Cell. Biochem. 17F, 262-269.
57. Garewal, H.S. (1995) Antioxidants in oral cancer prevention. Am. J. Clin. Nutr. Suppl., in press.
58. Van Poppel, G., Kok, F.J. and Hermus, R.J.J. (1992) Beta-carotene supplementation in smokers reduces the frequency of micronuclei in sputum. Br. J. Cancer 66, 1164-1168.
59. McLarty, J.W., Holiday, D.B., Girard, W.M., Yanagihara, R.H., Kummet, T.D. and Greenberg, S.D. (1995) Beta-carotene, vitamin A and lung cancer chemoprevention: results of an intermediate endpoint study. Am. J. Clin. Nutr. Suppl., in press.
60. Lippman, S.M., Benner, S.E. and Hong, W.K. (1994) Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis. Cancer Res. 54, 2025S-2028S.
61. Dawsey, S.M., Wang, G.Q., Taylor, P.R., Li, J.-Y., Blot, W.J., Li, B., Lewin, K.J., Liu, F.-S., Weinstein, W.M., Wiggett, S., Wang, H., Mark, S.D., Yu, Y. and Yang C.S. (1994) Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the dysplasia trial in Linxian, China. Cancer Epidemiol. Biomark. Prev. 3, 167-172.
62. Mark, S.D., Liu, S.F., Li, J.Y., Gail, M.H., Shen, Q., Dawsey, S.M., Liu, F., Taylor, P.R., Li, B. and Blot, W.J. (1994) The effect of vitamin and mineral supplementation on esophageal cytology: results from the Linxian dysplasia trial. Int. J. Cancer 57, 162-166.
63. Schatzkin, A., Freedman, L.S., Dawsey, S.M. and Lanza, E. (1994) Interpreting precursor studies: what polyp trials tell us about large-bowel cancer. J. Nat. Cancer Inst. 86, 1053-1057.
64. Greenberg, E.R., Baron, J.A., Tosteson, T.D., Freeman, D.H., Beck, G.J., Bond J.H., Colacchio, T.A., Coller, J.A., Frankl, H.D., Haile, R.W., Mandel, J.S., Nierenberg, D.W., Rothstein, R., Snover, D.C., Stevens, M.M., Summrs, R.W. and van Stolk R.U. (1994) A clincial trial of antioxidant vitamins to prevent colorectal adenoma. N. Engl. J. Med. 331, 141-147.
65. Burke, H.B.; de Leon, M.P. and Roncucci, L. (1994) Antioxidant vitamins and colorectal adenoma (letters). N. Engl. J. Med. 331, 1720.
66. Neugut, A.I.; Schatzkin, A., Freedman, L.S., Dawsey, S.M. and Kanza, E. (1994) Interpreting precursor studies; what polyp trials tell us about large-bower cancer (letters). J. Nat. Cancer Inst. 86, 1648-1649.
67. Cahill, R.J., O'Sullivan, K.R., Mathias, P.M., Beattie, S., Hamilton H. and Morain, C.O. (1993) Effects of vitamin antioxidant supplementation on cell kinetics of patients with adenomatous polyps. Gut. 34, 963-967.
68. Phillips, R.W., Kikendall, J.W., Luk, G.D., Willis, S.M., Murphy, J.R., Maydonovitch, C., Bowen, P.E., Stacewicz-Sapuntzakis and Wong, R.K.K. (1993) β-Carotene inhibits rectal mucosal ornithtne decarboxylase activity in colon cancer patients. Cancer Res. 53, 3723-3725.
69. Bukin, Y.V., Zaridze, D.G., Draudin-Krylenko, V.A., Orlov, E.N., Sigacheva, N.N.A., Dawei, F., Kurtzman, M.Y., Schlenskaya, I.N., Gorbacheva, O.N., Nechipai, A.M., Kuvschinov, Y.P., Poddubny, B.K. and Maximovitch, D.M. (1993) Effect of beta-carotene supplementation on the activity of ornithine decarboxylase (ODC) in stomach mucosa of patients with chronic atrophic gastritis. Eur. J. Cancer Prev. 2, 61-68.
70. Kahl-Rainer, P. and Marian, B. (1994) Retinoids inhibit protein kinase C-dependent transduction of 1,2-diglyceride signals in human colonic tumor cells. Nutr. Cancer 21, 157-168.
71. Frommel, T.O., Lietz, H. and Mobarhan, S. (1994) Expression of mRNA for the gap-junctional protein connexin43 in human colonic tissue is variable in response to β-carotene supplementation. Nutr. Cancer 22, 257-265.
72. Zhang, L.-X., Acevedo, P., Guo, H. and Bertram, J.S. (1995) Upregulation of gap junctional communication and connexin43 gene expression by carotenoids in human dermal fibroblasts but not in human keratinocytes. Molec. Carcinogenesis 12, 50-58.
73. Boone, C.W., Kelloff, G.J. and Steele, V.E. (1992) Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy. Cancer Res. 52, 1651-1659.
74. Palan, P.R., Mikhail, M.S., Basu, J. and Romney, S.L. (1991) Plasma levels of antioxidant β-carotene and α-tocopherol in uterine cervix dysplasias and cancer. Nutr. Cancer 15, 13-20.
75. Singh, V.N. and Gaby, S.K. (1991) Premalignant lesions: role of antioxidant vitamins and β-carotene in risk reduction and prevention of malignant transformation. Am. J. Clin. Nutr. 53, 386S-390S.
76. De Vet, H.C.W., Knipschild, P.G., Grol, M.E.C., Schouten, H.J.A. and Sturmans, F. (1991) The role of beta-carotene and other dietary factors in the aetiology of cervical dysplasia: results of a case-control study. Int. J. Epidemiol. 20, 603-610.
77. De Vet, H., Knipschild, P.G., Willebrand, D., Schouten, H.J.A. and Sturmans, F. (1991) The effect of beta-carotene on the regression and progression of cervical dysplasia: a clinical experiment. J. Clin. Epidemiol. 44, 273-283.
78. Meyskens, F.L. and Manetta, A. (1995) Prevention of cervical intraepithelial neoplasia and cervical cancer. Am. J. Clin. Nutr. Suppl., in press.
79. Muto, Y., Fujii, J., Shidoji, Y., Moriwaki, H., Kawaguchi, T and Noda, T. (1995) Growth retardation and down-regulation of EGF receptor by β-carotene in cervical dysplasia-derived cell lines. Am. J. Clin. Nutr. Suppl., in press.
80. Shklar, G. and Schwartz, J. (1994) A common pathway for the destruction of cancer cells: experimental evidence and clinical implications. Int. J. Oncology 4, 215-224.
81. Gosney, J.R., Butt, S.A., Gosney, M:Y. and Field, J.K. (1993) Exposure to cigarette smoke and expression of the protein encoded by the p53 gene in bronchial carcinoma. Ann NY Acad. Sci. 686, 243-248.
82. Shklar, G. and Schwartz, J. (1993) Oral cancer inhibition by micronutrients. The experimental basis for clinical trials. Oral Oncol. Eur. J. Cancer 29B, 9-16.
83. Gorgoulis, V., Rassidakis, G., Karameris, A., Giatromanolaki, A., Barbatis, C. and Kittas, C. (1994) Expression of p53 protein in laryngeal squamous cell carcinoma and dysplasia: possible correlation with human papillomavirus infection and clinicopathological findings. Virchows Arch. 425, 481-489.